Video

Dr. Nabors on Evolving Treatment Options for Brain Metastases

Louis B. Nabors, MD, of University of Alabama, Birmingham Comprehensive Cancer Center, discusses the evolving treatment landscape for patients with brain metastases.

Louis B. Nabors, MD, professor, University of Alabama, Birmingham Comprehensive Cancer Center, discusses the evolving treatment landscape for patients with brain metastases. For decades, as treatment for patients with brain metastases, physicians mainly relied on neurosurgery and radiation, and there were limited systemic therapy options.

Today, there is an increasing amount of systemic therapy options, says Nabors. These therapies have clearly demonstrated activity in metastatic disease in the central nervous system, he adds.

Research continues to focus on further developing these opportunities to better understand how to deploy systemic therapies in these patients. This will be a major goal over the next several years, he concludes.

<<< 2019 NCCN Annual Meeting

Related Videos
Timothy Hughes, MD, MBBS, FRACP, FRCPA
Ana Christina Garrido-Castro, MD
Jennifer R. Eads, MD, physician lead, GI Cancer Research, director, National Clinical Trials Network, Abramson Cancer Center, University of Pennsylvania, associate professor, clinical medicine (hematology-oncology), Penn Medicine, Perelman Center for Advanced Medicine
Jean-Marc Classe, MD, PhD, Nantes Université
Bradley McGregor, MD
Kevin Kalinsky, MD, MS
Petros Grivas, MD, PhD; and Chandler Park, MD, MSc, FACP
Arndt Vogel, MD
Suresh S. Ramalingam, MD, FACP, FASCO, professor, Department of Hematology and Medical Oncology, Roberto C. Goizueta Distinguished Chair for Cancer Research, Emory University School of Medicine, executive director, Winship Cancer Institute of Emory University, associate vice president, cancer, Woodruff Health Sciences Center